Q4 2025 earnings call recap: clonoSEQ MRD growth, 2026 revenue guidance, margins, cash burn and risks—read now.

Q3 2026 Management View CEO Jeffrey Tangney reported, “We delivered $185 million in revenue, which was 10% year-on-year ...

VeriSign Inc (VRSN) reports a robust Q4 with a 7.5% revenue increase and significant shareholder returns, despite challenges in net income and operating expenses.

First Majestic Silver stock fell 16% on Friday as silver prices have plunged 40% from all-time highs. The post Is This TSX ...

Q4 2025 earnings call recap: revenue, EPS, domain growth, 2026 guidance, AI-driven demand, dividends and risks—read key takeaways.

Non-GAAP gross margin improvements over the first six months were driven by higher equipment sales in lower-cost regions, as ...

Snap Inc (SNAP) reports a 10% revenue increase and 71% subscriber growth, despite challenges in daily active users and regulatory hurdles.

Apple fans got some welcome news tucked into the company's blockbuster earnings report: the tech giant is raising its ...

US Treasury sell-off impact on Bitcoin (BTC USD): Global markets face uncertainty as US Treasuries draw scrutiny. A sell-off in these safe assets could trigger a liquidity crunch. This event would ...

Teradyne Inc (TER) reports robust fourth-quarter performance with significant gains in AI-driven revenue and strategic market positioning.

Athena Gold Corp CEO Koby Kushner joined Steve Darling from the Vancouver Resources Investment Conference to share news about ...

Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.